Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy

Autor:	Ignacio Conget, Luis Bianchi, Josep Mallolas, Elisabet Buira, José Luis Santiago Blanco, José M. Gatell, Roser Casamitjana, Miguel A. Garcia-Viejo, Esteban Martínez
Rok vydání:	2000
Předmět:	Microbiology (medical) Adult Blood Glucose Cyclopropanes Male medicine.medical_specialty Efavirenz Time Factors Lipodystrophy medicine.medical_treatment HIV Infections Body Mass Index chemistry.chemical_compound Insulin resistance Internal medicine Oxazines medicine Humans Protease inhibitor (pharmacology) Protease Inhibitors Triglyceride business.industry Insulin Middle Aged Viral Load medicine.disease Impaired fasting glucose Lipids Benzoxazines Infectious Diseases Endocrinology Treatment Outcome chemistry Adipose Tissue Alkynes HIV-1 Body Constitution RNA Viral Reverse Transcriptase Inhibitors Female business Viral load
Zdroj:	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 31(5)
ISSN:	1058-4838
Popis:	We prospectively followed 20 consecutive patients with human immunodeficiency virus type 1 (HIV-1) with viral loads of
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4e6d9ff06812b83945d8d827d42be65 https://pubmed.ncbi.nlm.nih.gov/11073762 Zobrazit plný text záznamu